Get the Stockscreener App
9.98
0.10%
-0.010
After Hours:
9.98
Apogee Acquisition Corp stock is traded at $9.98, with a volume of 1,618.
It is down -0.10% in the last 24 hours and down -0.10% over the past month.
Apogee Acquisition Corp is a blank check company.
See More
Previous Close:
$9.99
Open:
$9.98
24h Volume:
1,618
Relative Volume:
0.02
Market Cap:
$234.23M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+0.10%
1M Performance:
-0.10%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$9.98
$9.98
1-Week Range:
$9.95
$10.00
52-Week Range:
$9.94
$10.01
Apogee Acquisition Corp Stock (AACP) Company Profile
Name
Apogee Acquisition Corp
Sector
Industry
Phone
771.210.4643
Address
2106 HOUSE AVE SUITE 375, CHEYENNE
Compare AACP vs LION, XXI, UMAC, CCXI, DMII
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AACP
Apogee Acquisition Corp
|
9.98 | 234.47M | 0 | 0 | 0 | 0.00 |
LION
Lionsgate Studios Corp
|
13.29 | 3.86B | 2.63B | -175.60M | 11.40M | -0.7173 |
XXI
Twenty One Capital Inc
|
5.31 | 1.78B | 0 | 4.35M | 456.40K | 0.3397 |
UMAC
Unusual Machines Inc
|
18.68 | 823.01M | 17.25M | -5.64M | -40.16M | -0.3337 |
CCXI
Churchill Capital Corp Xi
|
15.97 | 798.74M | 0 | 0 | 0 | 0.0647 |
DMII
Drugs Made In America Acquisition Ii Corp
|
10.10 | 642.73M | 0 | 8.58M | -1.11M | 0.134 |
Apogee Acquisition Corp Stock (AACP) Latest News
Apogee Therapeutics (NASDAQ: APGE) backs AbbVie’s $135.11‑per‑share all‑cash deal - Stock Titan
Price to book forward of Apogee Acquisition Corp – NASDAQ:AACP - TradingView
Apogee Acquisition (AACP) Stock Trends and Sentiment 2026 - MarketBeat
Enterprise value to revenue forward of Apogee Acquisition Corp – NASDAQ:AACP - TradingView
Apogee Acquisition Corp Rings the Nasdaq Stock Market Closing Bell - Nasdaq
Apogee Acquisition Corp Rings the Closing Bell - Nasdaq
Price to sales forward of Apogee Acquisition Corp – NASDAQ:AACP - TradingView
Iron Dome Acquisition Corporation Rings the Nasdaq Stock Market Opening Bell - Nasdaq
AACPU Technical Analysis | Trend, Signals & Chart Patterns - ChartMill
Price to sales forward of Apogee Acquisition Corp – BOATS:AACPR - TradingView
AACPR Stock Price, News & Analysis - Stock Titan
APOGEE ACQUISITION (AACPW) Stock Price, News & Analysis - Stock Titan
Price to sales forward of Apogee Acquisition Corp – NASDAQ:AACPR - TradingView
AbbVie acquires Apogee Therapeutics for $10.9 billion - qz.com
Apogee Therapeutics (APGE) Proxy filing Summary - Quartr
AbbVie to buy Apogee Therapeutics (APGE) for $135.11 per share — significant premium - Stock Titan
Enterprise value to EBITDA forward of Apogee Acquisition Corp – NASDAQ:AACP - TradingView
Apogee Enterprises Completes $115 Million Acquisition of Kalwall Companies to Expand Architectural Solutions - Minichart
H.C. Wainwright Keeps Buy Rating on Oruka (ORKA) After Apogee Acquisition News - Insider Monkey
Apogee completes strategic acquisition of Keller Companies - TipRanks
Apogee Enterprises completes Kalwall acquisition for $115 million - Investing.com
Apogee Enterprises completes acquisition of Kalwall Companies - scanx.trade
Apogee Enterprises, Inc. acquired Kalwall Corporation from the Keller family. - marketscreener.com
Ares Acquisition Corporation III Announces Pricing of Upsized $345 Million Initial Public Offering - Yahoo Finance
Enterprise value to EBIT forward of Apogee Acquisition Corp – NASDAQ:AACPW - TradingView
AbbVie Announces $10.9 Billion Acquisition of Apogee Therapeutics - HarianBasis.co
Enterprise value to revenue forward of Apogee Acquisition Corp – BOATS:AACPU - TradingView
Price to sales forward of Apogee Acquisition Corp – BOATS:AACPU - TradingView
Enterprise value to revenue forward of Apogee Acquisition Corp – NASDAQ:AACPW - TradingView
Deal Dispatch: Penske Buys Vox Media's Digital Brands, AbbVie Acquires Apogee Therapeutics For $10.9 Bill - Benzinga
AACPR|Apogee Acquisition Rights|| - TradingKey
Price to book forward of Apogee Acquisition Corp – NASDAQ:AACPU - TradingView
Price to sales forward of Apogee Acquisition Corp – NASDAQ:AACPU - TradingView
Mizuho downgrades Apogee Therapeutics stock on AbbVie acquisition - Investing.com
Mizuho downgrades Apogee Therapeutics stock on AbbVie acquisition By Investing.com - Investing.com Canada
After Apogee, 3 More Biotech Buyout Targets Wall Street Can’t Stop Watching - Yahoo Finance
AbbVie Acquires Apogee Therapeutics for 10.9 Billion Dollars - HarianBasis.co
Cash buyout for Apogee (NASDAQ: APGE) at $135.11 a share - Stock Titan
AACP|Apogee Acquisition Ord Shs Class A|Price:9.960|Chg%:0.00 - TradingKey
Wells Fargo Maintains Overweight on AbbVie (ABBV), Sees Value in Apogee Acquisition - Insider Monkey
AbbVie to Acquire Apogee Therapeutics, Deepening Immunology Portfolio - Investing News Network
Apogee Therapeutics (APGE) Hits Fresh High on AbbVie $10.9B Merger - Yahoo Finance
AbbVie: Apogee Acquisition Brings Significant Weight to Immunology Pipeline - Morningstar
AbbVie sharpens immunology focus with $10.9 billion Apogee deal - 102.7 WBOW
AbbVie: Why The Pharma Wins Twice With Its Apogee Acquisition (NASDAQ:APGE) - Seeking Alpha
AbbVie to Acquire Apogee Therapeutics for $10.9B - Genetic Engineering and Biotechnology News
AbbVie Acquires Apogee Therapeutics in 10.9 Billion Dollar Deal - HarianBasis.co
Apogee Enterprises Acquires Kalwall Companies for 115 Million Dollars - HarianBasis.co
AbbVie to acquire Apogee, staking nearly $11B on long-acting autoimmune drugs - BioPharma Dive
Apogee Enterprises (APOG) Makes a $115 Million Bet; Could This Acquisition Reshape Its Growth Story? - Insider Monkey
AbbVie Buys Apogee for $10.9 Billion to Acquire Inflammatory Disease Drug Pipeline - streamlinefeed.co.ke
Apogee Acquisition Corp Stock (AACP) Financials Data
There is no financial data for Apogee Acquisition Corp (AACP). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.08%
0.47%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):